As a result, we found that HS-173 recovered the MET process as follows: the expression of Ecadherin was increased, whereas that of Vimentin was strongly decreased in TGF-β-induced pancreatic cancer cells. This evidence concerns the gene CDH1 and familial pancreatic carcinoma.